Prudential Financial
OCUL icon

Prudential Financial’s Ocular Therapeutix OCUL Stock Holding History

Prudential Financial’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
33,700
+4,430
+15% +$40.2K ﹤0.01% 2067
2026
Q1 		$248K Buy
29,270
+18,060
+161% +$172K ﹤0.01% 2078
2025
Q4 		$136K Sell
11,210
-7,555
-40% -$91.8K ﹤0.01% 2102
2025
Q3 		$219K Buy
18,765
+65
+0.3% +$777 ﹤0.01% 2195
2025
Q2 		$174K Buy
18,700
+6,855
+58% +$53.7K ﹤0.01% 2233
2025
Q1 		$86.8K Buy
11,845
+320
+3% +$2.46K ﹤0.01% 2145
2024
Q4 		$98.4K Hold
11,525
– – ﹤0.01% 2149
2024
Q3 		$100K Sell
11,525
-70
-0.6% -$577 ﹤0.01% 2577
2024
Q2 		$79.3K Sell
11,595
-3,410
-23% -$21.1K ﹤0.01% 2565
2024
Q1 		$137K Buy
+15,005
New +$106K ﹤0.01% 2503

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential Financial's OCUL Position: Q2 2026 in Review

Prudential Financial increased its Ocular Therapeutix (OCUL) stake by 15% in Q2 2026, buying an estimated $40.2K and bringing the position to 33,700 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #2067.

Prudential Financial first reported a position in OCUL in Q1 2024 and has held it in 10 quarters since. 263 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Prudential Financial held 33,700 shares of Ocular Therapeutix worth $331K as of Q2 2026.
  • Prudential Financial bought 4,430 Ocular Therapeutix shares in Q2 2026, an estimated $40.2K.
  • Ocular Therapeutix made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2067 holding.
  • Prudential Financial first reported a position in Ocular Therapeutix in Q1 2024 and has held it in 10 quarters since.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.